response_type,Drug,Primary Tumor type,Association,gene,mutation,cDNA,gDNA,trancipt,Drug full name
Missense,Nilotinib,Chronic myeloid leukemia,Resistant,ABL1,E255K,c.763G>A,chr9:g.133738363G>A,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Resistant,ABL1,E255V,c.764A>T,chr9:g.133738364A>T,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Resistant,ABL1,Y253H,c.757T>C,chr9:g.133738357T>C,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Resistant,ABL1,F359V,c.1075T>G,chr9:g.133748414T>G,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Resistant,ABL1,F359C,c.1076T>G,chr9:g.133748415T>G,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Resistant,ABL1,F359I,c.1075T>A,chr9:g.133748414T>A,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Responsive,ABL1,F359V,c.1075T>G,chr9:g.133748414T>G,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Responsive,ABL1,F359C,c.1076T>G,chr9:g.133748415T>G,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Responsive,ABL1,F359I,c.1075T>A,chr9:g.133748414T>A,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Responsive,ABL1,Y253H,c.757T>C,chr9:g.133738357T>C,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Responsive,ABL1,E255K,c.763G>A,chr9:g.133738363G>A,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Responsive,ABL1,E255V,c.764A>T,chr9:g.133738364A>T,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,I242T,c.725T>C,chr9:g.133738325T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,M244V,c.730A>G,chr9:g.133738330A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,K247R,c.740A>G,chr9:g.133738340A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L248V,c.742C>G,chr9:g.133738342C>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,G250E,c.749G>A,chr9:g.133738349G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,G250R,c.748G>A,chr9:g.133738348G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Q252R,c.755A>G,chr9:g.133738355A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Q252H,c.756G>T,chr9:g.133738356G>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Y253F,c.758A>T,chr9:g.133738358A>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Y253H,c.757T>C,chr9:g.133738357T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E255K,c.763G>A,chr9:g.133738363G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E255V,c.764A>T,chr9:g.133738364A>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,M237V,c.709A>G,chr9:g.133738309A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E258D,c.774G>C,chr9:g.133738374G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,W261L,c.782G>T,chr9:g.133738382G>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L273M,c.817T>A,chr9:g.133738417T>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E275K,c.823G>A,chr9:g.133747516G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E275Q,c.823G>C,chr9:g.133747516G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,D276G,c.827A>G,chr9:g.133747520A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,T277A,c.829A>G,chr9:g.133747522A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E279K,c.835G>A,chr9:g.133747528G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,V280A,c.839T>C,chr9:g.133747532T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,V289A,c.866T>C,chr9:g.133747559T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,V289I,c.865G>A,chr9:g.133747558G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E292V,c.875A>T,chr9:g.133747568A>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E292Q,c.874G>C,chr9:g.133747567G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,I293V,c.877A>G,chr9:g.133747570A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L298V,c.892C>G,chr9:g.133747585C>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F311L,c.931T>C,chr9:g.133748270T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F311I,c.931T>A,chr9:g.133748270T>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,T315I,c.944C>T,chr9:g.133748283C>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F317L,c.949T>C,chr9:g.133748288T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F317V,c.949T>G,chr9:g.133748288T>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F317I,c.949T>A,chr9:g.133748288T>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F317C,c.950T>G,chr9:g.133748289T>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Y320C,c.959A>G,chr9:g.133748298A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L324Q,c.971T>A,chr9:g.133748310T>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Y342H,c.1024T>C,chr9:g.133748363T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,M343T,c.1028T>C,chr9:g.133748367T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A344V,c.1031C>T,chr9:g.133748370C>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A350V,c.1049C>T,chr9:g.133748388C>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,M351T,c.1052T>C,chr9:g.133748391T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E355D,c.1065G>C,chr9:g.133748404G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E355G,c.1064A>G,chr9:g.133748403A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E355A,c.1064A>C,chr9:g.133748403A>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F359V,c.1075T>G,chr9:g.133748414T>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F359I,c.1075T>A,chr9:g.133748414T>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F359C,c.1076T>G,chr9:g.133748415T>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F359L,c.1075T>C,chr9:g.133748414T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,D363Y,c.1087G>T,chr9:g.133750256G>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L364I,c.1090C>A,chr9:g.133750259C>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A365V,c.1094C>T,chr9:g.133750263C>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A366G,c.1097C>G,chr9:g.133750266C>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L370P,c.1109T>C,chr9:g.133750278T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,V371A,c.1112T>C,chr9:g.133750281T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E373K,c.1117G>A,chr9:g.133750286G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,V379I,c.1135G>A,chr9:g.133750304G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A380T,c.1138G>A,chr9:g.133750307G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F382L,c.1144T>C,chr9:g.133750313T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L384M,c.1150C>A,chr9:g.133750319C>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L387M,c.1159T>A,chr9:g.133750328T>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L387F,c.1161G>T,chr9:g.133750330G>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,L387V,c.1159T>G,chr9:g.133750328T>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,M388L,c.1162A>C,chr9:g.133750331A>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,Y393C,c.1178A>G,chr9:g.133750347A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,H396P,c.1187A>C,chr9:g.133750356A>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,H396R,c.1187A>G,chr9:g.133750356A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,H396A,c.1186_1187delCAinsGC,chr9:g.133750355_133750356delCAinsGC,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A397P,c.1189G>C,chr9:g.133750358G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,S417F,c.1250C>T,chr9:g.133750419C>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,S417Y,c.1250C>A,chr9:g.133750419C>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,I418S,c.1253T>G,chr9:g.133750422T>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,I418V,c.1252A>G,chr9:g.133750421A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,A433T,c.1297G>A,chr9:g.133753828G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,S438C,c.1313C>G,chr9:g.133753844C>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E450K,c.1348G>A,chr9:g.133753879G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E450G,c.1349A>G,chr9:g.133753880A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E450A,c.1349A>C,chr9:g.133753880A>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E450V,c.1349A>T,chr9:g.133753880A>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E453K,c.1357G>A,chr9:g.133753888G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E453G,c.1358A>G,chr9:g.133753889A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E453A,c.1358A>C,chr9:g.133753889A>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E453V,c.1358A>T,chr9:g.133753889A>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E459K,c.1375G>A,chr9:g.133753906G>A,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E459G,c.1376A>G,chr9:g.133753907A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E459A,c.1376A>C,chr9:g.133753907A>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E459V,c.1376A>T,chr9:g.133753907A>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,M472I,c.1416G>C,chr9:g.133753947G>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,P480L,c.1439C>T,chr9:g.133755470C>T,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,F486S,c.1457T>C,chr9:g.133755488T>C,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Chronic myeloid leukemia,Resistant,ABL1,E507G,c.1520A>G,chr9:g.133755893A>G,ENST00000318560,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,T315A,c.943A>G,chr9:g.133748282A>G,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F317L,c.949T>C,chr9:g.133748288T>C,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F317V,c.949T>G,chr9:g.133748288T>G,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F317I,c.949T>A,chr9:g.133748288T>A,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F317C,c.950T>G,chr9:g.133748289T>G,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,Y253H,c.757T>C,chr9:g.133738357T>C,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,E255K,c.763G>A,chr9:g.133738363G>A,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,E255V,c.764A>T,chr9:g.133738364A>T,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F359V,c.1075T>G,chr9:g.133748414T>G,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F359C,c.1076T>G,chr9:g.133748415T>G,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Responsive,ABL1,F359I,c.1075T>A,chr9:g.133748414T>A,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Responsive,ABL1,T315A,c.943A>G,chr9:g.133748282A>G,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Responsive,ABL1,F317L,c.949T>C,chr9:g.133748288T>C,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Responsive,ABL1,F317V,c.949T>G,chr9:g.133748288T>G,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Responsive,ABL1,F317I,c.949T>A,chr9:g.133748288T>A,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Responsive,ABL1,F317C,c.950T>G,chr9:g.133748289T>G,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Nilotinib,Chronic myeloid leukemia,Responsive,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,BOSUTINIB ,Chronic myeloid leukemia,Resistant,ABL1,T315I,c.944C>T,chr9:g.133748283C>T,ENST00000318560,Bosutinib (BCR-ABL inhibitor  3rd gen)
Missense,Ponatinib,Chronic myeloid leukemia;Acute lymphoblastic leukemia,Responsive,ABL1,T315I,c.944C>T,chr9:g.133748283C>T,ENST00000318560,Ponatinib (BCR-ABL inhibitor 3rd gen&Pan-TK inhibitor)
Missense,Axitinib,Any cancer type,Responsive,ABL1,T315I,c.944C>T,chr9:g.133748283C>T,ENST00000318560,Axitinib (VEGFR inhibitor)
Missense,Ponatinib,Chronic myeloid leukemia,Responsive,ABL1,T315I,c.944C>T,chr9:g.133748283C>T,ENST00000318560,Ponatinib (BCR-ABL inhibitor 3rd gen&Pan-TK inhibitor)
Missense,Cabozantinib,Any cancer type,Responsive,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Cabozantinib (Pan-kinase inhibitor)
Missense,Crizotinib,Any cancer type,Responsive,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Crizotinib (ALK inhibitor)
Missense,Foretinib,Any cancer type,Responsive,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Foretinib\xa0 (MET inhibitor)
Missense,Vandetanib,Any cancer type,Responsive,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Vandetanib (Pan-TK inhibitor)
Missense,Dasatinib,Chronic myeloid leukemia,Resistant,ABL1,V299L,c.895G>C,chr9:g.133747588G>C,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Resistant,ABL1,T315A,c.943A>G,chr9:g.133748282A>G,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Resistant,ABL1,F317L,c.949T>C,chr9:g.133748288T>C,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Resistant,ABL1,F317V,c.949T>G,chr9:g.133748288T>G,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Resistant,ABL1,F317I,c.949T>A,chr9:g.133748288T>A,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Chronic myeloid leukemia,Resistant,ABL1,F317C,c.950T>G,chr9:g.133748289T>G,ENST00000318560,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Lorlatinib,Lung adenocarcinoma,Responsive,ALK,C1156Y,c.3467G>A,chr2:g.29445258C>T,ENST00000389048,Lorlatinib (ALK&ROS1 inhibitor)
Missense,Crizotinib,Non-small cell lung,Resistant,ALK,C1156Y,c.3467G>A,chr2:g.29445258C>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Non-small cell lung,Resistant,ALK,L1196M,c.3586C>A,chr2:g.29443631G>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Brigatinib,Lung adenocarcinoma,Responsive,ALK,E1408V,c.4223A>T,chr2:g.29416730T>A,ENST00000389048,Brigatinib (Pan-TK inhibitor)
Missense,Crizotinib,Glioma,Resistant,ALK,F1174L,c.3520T>C,chr2:g.29443697A>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Acute myeloid leukemia,Responsive,ALK,F856S,c.2567T>C,chr2:g.29455235A>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Acute myeloid leukemia,Responsive,ALK,A348D,c.1043C>A,chr2:g.29754892G>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Resistant,ALK,G1123S,c.3367G>A,chr2:g.29445466C>T,ENST00000389048,Ceritinib (ALK inhibitor)
Missense,Alectinib,Lung adenocarcinoma,Resistant,ALK,I1171T,c.3512T>C,chr2:g.29445213A>G,ENST00000389048,Alectinib (ALK inhibitor)
Missense,Brigatinib,Lung adenocarcinoma,Responsive,ALK,L1196M,c.3586C>A,chr2:g.29443631G>T,ENST00000389048,Brigatinib (Pan-TK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,L1196M,c.3586C>A,chr2:g.29443631G>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,L1152R,c.3455T>G,chr2:g.29445270A>C,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,C1156Y,c.3467G>A,chr2:g.29445258C>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,F1174L,c.3520T>C,chr2:g.29443697A>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,G1202R,c.3604G>A,chr2:g.29443613C>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,S1206Y,c.3617C>A,chr2:g.29443600G>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,G1269A,c.3806G>C,chr2:g.29432682C>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ALK,I1171T,c.3512T>C,chr2:g.29445213A>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Responsive,ALK,L1196M,c.3586C>A,chr2:g.29443631G>T,ENST00000389048,Ceritinib (ALK inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Responsive,ALK,S1206Y,c.3617C>A,chr2:g.29443600G>T,ENST00000389048,Ceritinib (ALK inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Responsive,ALK,G1269A,c.3806G>C,chr2:g.29432682C>G,ENST00000389048,Ceritinib (ALK inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Responsive,ALK,I1171T,c.3512T>C,chr2:g.29445213A>G,ENST00000389048,Ceritinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Responsive,ALK,L1198F,c.3592C>T,chr2:g.29443625G>A,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Glioma,Responsive,ALK,R1275Q,c.3824G>A,chr2:g.29432664C>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Glioma,Responsive,ALK,G1128A,c.3383G>C,chr2:g.29445450C>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Glioma,Responsive,ALK,I1171N,c.3512T>A,chr2:g.29445213A>T,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Glioma,Responsive,ALK,R1192P,c.3575G>C,chr2:g.29443642C>G,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Glioma,Responsive,ALK,F1245C,c.3734T>G,chr2:g.29436859A>C,ENST00000389048,Crizotinib (ALK inhibitor)
Missense,Enzalutamide,Prostate adenocarcinoma,Resistant,AR,F877L,c.2629T>C,chrX:g.66943549T>C,ENST00000374690,Enzalutamide (AR inhibitor)
Missense,Abiraterone,Prostate adenocarcinoma,Resistant,AR,L702H,c.2105T>A,chrX:g.66931463T>A,ENST00000374690,Abiraterone (AR inhibitor)
Missense,Abiraterone,Prostate adenocarcinoma,Resistant,AR,T878A,c.2632A>G,chrX:g.66943552A>G,ENST00000374690,Abiraterone (AR inhibitor)
Missense,Flutamide,Prostate adenocarcinoma,Resistant,AR,T878A,c.2632A>G,chrX:g.66943552A>G,ENST00000374690,Flutamide (AR inhibitor)
Missense,Sorafenib,Lung adenocarcinoma,Responsive,ARAF,S214C,c.641C>G,chrX:g.47426121C>G,ENST00000377045,Sorafenib (Pan-TK inhibitor)
Missense,Sorafenib,Cutaneous melanoma,Responsive,BRAF,D594G,c.1781A>G,chr7:g.140453154T>C,ENST00000288602,Sorafenib (Pan-TK inhibitor)
Missense,Sorafenib,Cutaneous melanoma,Responsive,BRAF,G469E,c.1406G>A,chr7:g.140481402C>T,ENST00000288602,Sorafenib (Pan-TK inhibitor)
Missense,Dasatinib,Lung adenocarcinoma,Responsive,BRAF,G466V,c.1397G>T,chr7:g.140481411C>A,ENST00000288602,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Trametinib,Cutaneous melanoma,Responsive,BRAF,K601R,c.1802A>G,chr7:g.140453133T>C,ENST00000288602,"MEK inhibitors (Trametinib,etc)"
Missense,Trametinib,Cutaneous melanoma,Responsive,BRAF,L597R,c.1790T>G,chr7:g.140453145A>C,ENST00000288602,"MEK inhibitors (Trametinib,etc)"
Missense,Trametinib,Cutaneous melanoma,Responsive,BRAF,V600R,c.1798_1799delGTinsAG,chr7:g.140453136_140453137delACinsCT,ENST00000288602,"MEK inhibitors (Trametinib,etc)"
Missense,Vemurafenib,Cutaneous melanoma,Responsive,BRAF,V600D,c.1799_1800delTGinsAC,chr7:g.140453135_140453136delCAinsGT,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Responsive,BRAF,V600K,c.1798_1799delGTinsAA,chr7:g.140453136_140453137delACinsTT,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Responsive,BRAF,V600M,c.1798G>A,chr7:g.140453137C>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Responsive,BRAF,V600G,c.1799T>G,chr7:g.140453136A>C,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Responsive,BRAF,V600R,c.1798_1799delGTinsAG,chr7:g.140453136_140453137delACinsCT,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Dabrafenib,Non-small cell lung,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Dabrafenib (BRAF inhibitor)
Missense,Dabrafenib,Cutaneous melanoma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Dabrafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Selumetinib,Pediatric glioma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Selumetinib (MEK inhibitor)
Missense,Vemurafenib,Malignant astrocytoma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Dabrafenib,Gastrointestinal stromal,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Dabrafenib (BRAF inhibitor)
Missense,Dabrafenib,Lung adenocarcinoma;Thyroid,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Dabrafenib (BRAF inhibitor)
Missense,Vemurafenib,Lung adenocarcinoma;Hairy-Cell leukemia;Myeloma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Thyroid carcinoma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,PLX-4720,Malignant astrocytoma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,PLX4720 (BRAF inhibitor)
Missense,Vemurafenib,Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis,Responsive,BRAF,V600D,c.1799_1800delTGinsAC,chr7:g.140453135_140453136delCAinsGT,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis,Responsive,BRAF,V600K,c.1798_1799delGTinsAA,chr7:g.140453136_140453137delACinsTT,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis,Responsive,BRAF,V600M,c.1798G>A,chr7:g.140453137C>T,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis,Responsive,BRAF,V600G,c.1799T>G,chr7:g.140453136A>C,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis,Responsive,BRAF,V600R,c.1798_1799delGTinsAG,chr7:g.140453136_140453137delACinsCT,ENST00000288602,Vemurafenib (BRAF inhibitor)
Missense,Trametinib,Cutaneous melanoma,Responsive,BRAF,V600E,c.1799T>A,chr7:g.140453136A>T,ENST00000288602,Trametinib (MEK inhibitor)
Missense,Trametinib,Cutaneous melanoma,Responsive,BRAF,V600K,c.1798_1799delGTinsAA,chr7:g.140453136_140453137delACinsTT,ENST00000288602,Trametinib (MEK inhibitor)
Missense,Dabrafenib,Cutaneous melanoma,Responsive,BRAF,V600R,c.1798_1799delGTinsAG,chr7:g.140453136_140453137delACinsCT,ENST00000288602,Dabrafenib (BRAF inhibitor)
Missense,Dasatinib,Lung adenocarcinoma,Responsive,BRAF,Y472C,c.1415A>G,chr7:g.140481393T>C,ENST00000288602,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Ibrutinib,Chronic lymphocytic leukemia,Resistant,BTK,C481S,c.1441T>A,chrX:g.100611165A>T,ENST00000308731,Ibrutinib (BTK inhibitor)
Missense,Dasatinib,Myelodisplasic proliferative syndrome,Responsive,CBL,Y371H,c.1111T>C,chr11:g.119148891T>C,ENST00000264033,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Myelodisplasic proliferative syndrome,Responsive,CBL,C384R,c.1150T>C,chr11:g.119148930T>C,ENST00000264033,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Imatinib,Myelodisplasic proliferative syndrome,Responsive,CSF1R,Y571D,c.1711T>G,chr5:g.149441328A>C,ENST00000286301,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,I638F,c.1912A>T,chr1:g.162745497A>T,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,L239R,c.716T>G,chr1:g.162729630T>G,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,G253C,c.757G>T,chr1:g.162729671G>T,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,G774V,c.2321G>T,chr1:g.162748407G>T,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,L63V,c.187C>G,chr1:g.162724415C>G,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,G505S,c.1513G>A,chr1:g.162741822G>A,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,DDR2,S768R,c.2304T>G,chr1:g.162748390T>G,ENST00000367922,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Erlotinib,Lung squamous cell,Responsive,DDR2,S768R,c.2304T>G,chr1:g.162748390T>G,ENST00000367922,Erlotinib (EGFR inhibitor 1st gen)
Missense,Erlotinib,Glioma,Responsive,EGFR,A289V,c.866C>T,chr7:g.55221822C>T,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Erlotinib,Glioma,Responsive,EGFR,R108K,c.323G>A,chr7:g.55211080G>A,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Erlotinib,Glioma,Responsive,EGFR,G598V,c.1793G>T,chr7:g.55233043G>T,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Erlotinib,Glioma,Responsive,EGFR,T263P,c.787A>C,chr7:g.55221743A>C,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Osimertinib,Lung,Resistant,EGFR,C797S,c.2389T>A,chr7:g.55249091T>A,ENST00000275493,Osimertinib (EGFR inhibitor 3rd gen)
Missense,Lapatinib,Endometrium,Responsive,EGFR,E690K,c.2068G>A,chr7:g.55241620G>A,ENST00000275493,Lapatinib (ERBB2 inhibitor)
Missense,Erlotinib,Lung,Responsive,EGFR,K757R,c.2270A>G,chr7:g.55242500A>G,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Erlotinib,Lung,Responsive,EGFR,E746G,c.2237A>G,chr7:g.55242467A>G,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Rociletinib,Lung adenocarcinoma,Resistant,EGFR,L798I,c.2392C>A,chr7:g.55249094C>A,ENST00000275493,Rociletinib (EGFR inhibitor)
Missense,Osimertinib,Lung,Responsive,EGFR,L858R,c.2573T>G,chr7:g.55259515T>G,ENST00000275493,Osimertinib (EGFR inhibitor 3rd gen)
Missense,Erlotinib,Non-small cell lung,Responsive,EGFR,L858R,c.2573T>G,chr7:g.55259515T>G,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L858R,c.2573T>G,chr7:g.55259515T>G,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L861Q,c.2582T>A,chr7:g.55259524T>A,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719A,c.2156G>C,chr7:g.55241708G>C,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719S,c.2155G>A,chr7:g.55241707G>A,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719C,c.2155G>T,chr7:g.55241707G>T,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719D,c.2156G>A,chr7:g.55241708G>A,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L747S,c.2240T>C,chr7:g.55242470T>C,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,S768I,c.2303G>T,chr7:g.55249005G>T,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L861P,c.2582T>C,chr7:g.55259524T>C,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L861R,c.2582T>G,chr7:g.55259524T>G,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L858R,c.2573T>G,chr7:g.55259515T>G,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L861Q,c.2582T>A,chr7:g.55259524T>A,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719A,c.2156G>C,chr7:g.55241708G>C,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719S,c.2155G>A,chr7:g.55241707G>A,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719C,c.2155G>T,chr7:g.55241707G>T,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719D,c.2156G>A,chr7:g.55241708G>A,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L747S,c.2240T>C,chr7:g.55242470T>C,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,S768I,c.2303G>T,chr7:g.55249005G>T,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L861P,c.2582T>C,chr7:g.55259524T>C,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L861R,c.2582T>G,chr7:g.55259524T>G,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L861Q,c.2582T>A,chr7:g.55259524T>A,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719A,c.2156G>C,chr7:g.55241708G>C,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719S,c.2155G>A,chr7:g.55241707G>A,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719C,c.2155G>T,chr7:g.55241707G>T,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,G719D,c.2156G>A,chr7:g.55241708G>A,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L747S,c.2240T>C,chr7:g.55242470T>C,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,S768I,c.2303G>T,chr7:g.55249005G>T,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L861P,c.2582T>C,chr7:g.55259524T>C,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Afatinib,Non-small cell lung,Responsive,EGFR,L861R,c.2582T>G,chr7:g.55259524T>G,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L861Q,c.2582T>A,chr7:g.55259524T>A,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719A,c.2156G>C,chr7:g.55241708G>C,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719S,c.2155G>A,chr7:g.55241707G>A,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719C,c.2155G>T,chr7:g.55241707G>T,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,G719D,c.2156G>A,chr7:g.55241708G>A,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L747S,c.2240T>C,chr7:g.55242470T>C,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,S768I,c.2303G>T,chr7:g.55249005G>T,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L861P,c.2582T>C,chr7:g.55259524T>C,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Gefitinib,Non-small cell lung,Responsive,EGFR,L861R,c.2582T>G,chr7:g.55259524T>G,ENST00000275493,Gefitinib (EGFR inhibitor 1st gen)
Missense,Afatinib,Lung,Resistant,EGFR,T790M,c.2369C>T,chr7:g.55249071C>T,ENST00000275493,Afatinib (ERBB2 inhibitor&EGFR inhibitor 2nd gen)
Missense,Erlotinib,Lung,Resistant,EGFR,T790M,c.2369C>T,chr7:g.55249071C>T,ENST00000275493,Erlotinib (EGFR inhibitor 1st gen)
Missense,Osimertinib,Non-small cell lung,Responsive,EGFR,T790M,c.2369C>T,chr7:g.55249071C>T,ENST00000275493,Osimertinib (EGFR inhibitor 3rd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,EPHA2,G391R,c.1171G>A,chr1:g.16464489C>T,ENST00000358432,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Lung squamous cell,Responsive,EPHA2,G391R,c.1171G>A,chr1:g.16464489C>T,ENST00000358432,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Lapatinib,Breast adenocarcinoma,Responsive,ERBB2,D769Y,c.2305G>T,chr17:g.37880261G>T,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Responsive,ERBB2,D769H,c.2305G>C,chr17:g.37880261G>C,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Responsive,ERBB2,R896C,c.2686C>T,chr17:g.37881616C>T,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Responsive,ERBB2,V777L,c.2329G>C,chr17:g.37881000G>C,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Responsive,ERBB2,V842I,c.2524G>A,chr17:g.37881332G>A,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Responsive,ERBB2,G309A,c.926G>C,chr17:g.37868205G>C,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Resistant,ERBB2,K753E,c.2257A>G,chr17:g.37880213A>G,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,K753E,c.2257A>G,chr17:g.37880213A>G,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,L755S,c.2264T>C,chr17:g.37880220T>C,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,G309A,c.926G>C,chr17:g.37868205G>C,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,D769Y,c.2305G>T,chr17:g.37880261G>T,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,D769H,c.2305G>C,chr17:g.37880261G>C,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,R896C,c.2686C>T,chr17:g.37881616C>T,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,V777L,c.2329G>C,chr17:g.37881000G>C,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,V842I,c.2524G>A,chr17:g.37881332G>A,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Responsive,ERBB2,L869R,c.2606T>G,chr17:g.37881414T>G,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Neratinib,Breast adenocarcinoma,Resistant,ERBB2,T798I,c.2393C>T,chr17:g.37881064C>T,ENST00000269571,Neratinib (ERBB2 inhibitor)
Missense,Afatinib,Breast adenocarcinoma,Responsive,ERBB2,T798I,c.2393C>T,chr17:g.37881064C>T,ENST00000269571,Afatinib (ERBB2&EGFR inhibitor 2nd gen)
Missense,Lapatinib,Breast adenocarcinoma;Lung adenocarcinoma,Responsive,ERBB2,V659E,c.1976_1977delTTinsAG,chr17:g.37879601_37879602delTTinsAG,ENST00000269571,Lapatinib (ERBB2 inhibitor)
Missense,Afatinib,Bladder,Responsive,ERBB3,G284R,c.850G>A,chr12:g.56481922G>A,ENST00000267101,Afatinib (ERBB2&EGFR inhibitor 2nd gen)
Missense,Afatinib,Bladder,Responsive,ERBB3,R103G,c.307C>G,chr12:g.56478851C>G,ENST00000267101,Afatinib (ERBB2&EGFR inhibitor 2nd gen)
Missense,Afatinib,Bladder,Responsive,ERBB3,G284R,c.850G>A,chr12:g.56481922G>A,ENST00000267101,Afatinib (ERBB2&EGFR inhibitor 2nd gen)
Missense,Afatinib,Bladder,Responsive,ERBB3,V104M,c.310G>A,chr12:g.56478854G>A,ENST00000267101,Afatinib (ERBB2&EGFR inhibitor 2nd gen)
Missense,Afatinib,Bladder,Responsive,ERBB3,R103G,c.307C>G,chr12:g.56478851C>G,ENST00000267101,Afatinib (ERBB2&EGFR inhibitor 2nd gen)
Missense,Lapatinib,Any cancer type,Responsive,ERBB3,P262H,c.785C>A,chr12:g.56481857C>A,ENST00000267101,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Any cancer type,Responsive,ERBB3,G284R,c.850G>A,chr12:g.56481922G>A,ENST00000267101,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Any cancer type,Responsive,ERBB3,Q809R,c.2426A>G,chr12:g.56490980A>G,ENST00000267101,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Cutaneous melanoma,Responsive,ERBB4,E317K,c.949G>A,chr2:g.212578308C>T,ENST00000342788,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Cutaneous melanoma,Responsive,ERBB4,E452K,c.1354G>A,chr2:g.212566827C>T,ENST00000342788,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Cutaneous melanoma,Responsive,ERBB4,R544W,c.1630C>T,chr2:g.212537975G>A,ENST00000342788,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Cutaneous melanoma,Responsive,ERBB4,R393W,c.1177C>T,chr2:g.212570064G>A,ENST00000342788,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Cutaneous melanoma,Responsive,ERBB4,E872K,c.2614G>A,chr2:g.212295699C>T,ENST00000342788,Lapatinib (ERBB2 inhibitor)
Missense,Lapatinib,Breast adenocarcinoma,Resistant,ERBB4,H809G,c.2425_2426delCAinsGG,chr2:g.212426689_212426690delTGinsCC,ENST00000342788,"ERBB2 inhibitors (Lapatinib,etc)"
Missense,Fulvestrant,Breast adenocarcinoma,Resistant,ESR1,Y537S,c.1610A>C,chr6:g.152419923A>C,ENST00000440973,Fulvestrant (Hormonal therapy)
Missense,Selumetinib,Cutaneous melanoma,Responsive,GNA11,Q209L,c.626A>T,chr19:g.3118942A>T,ENST00000078429,Selumetinib (MEK inhibitor)
Missense,Selumetinib,Cutaneous melanoma,Responsive,GNA11,Q209P,c.626A>C,chr19:g.3118942A>C,ENST00000078429,Selumetinib (MEK inhibitor)
Missense,Vorinostat,Cutaneous melanoma,Responsive,GNA11,Q209L,c.626A>T,chr19:g.3118942A>T,ENST00000078429,Vorinostat (HDAC inhibitor)
Missense,Vorinostat,Cutaneous melanoma,Responsive,GNA11,Q209P,c.626A>C,chr19:g.3118942A>C,ENST00000078429,Vorinostat (HDAC inhibitor)
Missense,Enasidenib,Hematologic malignancies,Responsive,IDH2,R140K,c.418_419delCGinsAA,chr15:g.90631934_90631935delCGinsTT,ENST00000330062,AG-221 (IDH2 inhibitor)
Missense,Enasidenib,Hematologic malignancies,Responsive,IDH2,R172K,c.515G>A,chr15:g.90631838C>T,ENST00000330062,AG-221 (IDH2 inhibitor)
Missense,Ruxolitinib,Acute myeloid leukemia,Responsive,JAK2,V617F,c.1849G>T,chr9:g.5073770G>T,ENST00000381652,Ruxolitinib (JAK inhibitor)
Missense,Ruxolitinib,Myelofibrosis,Responsive,JAK2,V617F,c.1849G>T,chr9:g.5073770G>T,ENST00000381652,Ruxolitinib (JAK inhibitor)
Missense,Amiloride,Adrenal adenoma,Responsive,KCNJ5,L168R,c.503T>G,chr11:g.128781671T>G,ENST00000529694,Amiloride (Na-Ca chanel blocker)
Missense,Verapamil,Adrenal adenoma,Responsive,KCNJ5,L168R,c.503T>G,chr11:g.128781671T>G,ENST00000529694,Verapamil (Na-Ca chanel blocker)
Missense,Ponatinib,Gastrointestinal stromal,Responsive,KIT,A829P,c.2485G>C,chr4:g.55602664G>C,ENST00000288135,Ponatinib (BCR-ABL inhibitor 3rd gen&Pan-TK inhibitor)
Missense,Ponatinib,Gastrointestinal stromal,Responsive,KIT,V654A,c.1961T>C,chr4:g.55594258T>C,ENST00000288135,Ponatinib (BCR-ABL inhibitor 3rd gen&Pan-TK inhibitor)
Missense,Ponatinib,Gastrointestinal stromal,Responsive,KIT,T670I,c.2009C>T,chr4:g.55595519C>T,ENST00000288135,Ponatinib (BCR-ABL inhibitor 3rd gen&Pan-TK inhibitor)
Missense,Dasatinib,Acute myeloid leukemia,Responsive,KIT,D816V,c.2447A>T,chr4:g.55599321A>T,ENST00000288135,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Systemic mastocytosis,Responsive,KIT,D816V,c.2447A>T,chr4:g.55599321A>T,ENST00000288135,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Any cancer type,Responsive,KIT,D816Y,c.2446G>T,chr4:g.55599320G>T,ENST00000288135,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Any cancer type,Responsive,KIT,D816F,c.2446_2447delGAinsTT,chr4:g.55599320_55599321delGAinsTT,ENST00000288135,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Dasatinib,Any cancer type,Responsive,KIT,D816V,c.2447A>T,chr4:g.55599321A>T,ENST00000288135,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Sorafenib,Thymic,Responsive,KIT,D820E,c.2460T>G,chr4:g.55599334T>G,ENST00000288135,Sorafenib (Pan-TK inhibitor)
Missense,Imatinib,Cutaneous melanoma,Responsive,KIT,D820Y,c.2458G>T,chr4:g.55599332G>T,ENST00000288135,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Nilotinib,Cutaneous melanoma,Responsive,KIT,D820Y,c.2458G>T,chr4:g.55599332G>T,ENST00000288135,Nilotinib (BCR-ABL inhibitor 2nd gen)
Missense,Sunitinib,Thymic,Responsive,KIT,H697Y,c.2089C>T,chr4:g.55595599C>T,ENST00000288135,Sunitinib (Pan-TK inhibitor)
Missense,Sunitinib,Thymic,Responsive,KIT,H697Y,c.2089C>T,chr4:g.55595599C>T,ENST00000288135,Sunitinib (Pan-TK inhibitor)
Missense,Dasatinib,Acute myeloid leukemia,Responsive,KIT,N822K,c.2466T>G,chr4:g.55599340T>G,ENST00000288135,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Imatinib,Gastrointestinal stromal,Resistant,KIT,T670I,c.2009C>T,chr4:g.55595519C>T,ENST00000288135,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Thymic,Responsive,KIT,Y553N,c.1657T>A,chr4:g.55593591T>A,ENST00000288135,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Sunitinib,Thymic,Responsive,KIT,Y553N,c.1657T>A,chr4:g.55593591T>A,ENST00000288135,Sunitinib (Pan-TK inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Resistant,MAP2K1,E203K,c.607G>A,chr15:g.66774131G>A,ENST00000307102,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Resistant,MAP2K1,Q56P,c.167A>C,chr15:g.66727451A>C,ENST00000307102,Vemurafenib (BRAF inhibitor)
Missense,Vemurafenib,Cutaneous melanoma,Resistant,MAP2K1,K57E,c.169A>G,chr15:g.66727453A>G,ENST00000307102,Vemurafenib (BRAF inhibitor)
Missense,Trametinib,Any cancer type,Responsive,MAP2K1,Q56P,c.167A>C,chr15:g.66727451A>C,ENST00000307102,Trametinib (MEK inhibitor)
Missense,Crizotinib,Any cancer type,Responsive,MET,H1112L,c.3335A>T,chr7:g.116417464A>T,ENST00000318493,"MET inhibitors (Crizotinib,etc)"
Missense,Crizotinib,Any cancer type,Responsive,MET,V1110I,c.3328G>A,chr7:g.116417457G>A,ENST00000318493,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Any cancer type,Responsive,MET,H1112R,c.3335A>G,chr7:g.116417464A>G,ENST00000318493,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Any cancer type,Responsive,MET,M1268T,c.3803T>C,chr7:g.116423474T>C,ENST00000318493,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Any cancer type,Responsive,MET,R988C,c.2962C>T,chr7:g.116411923C>T,ENST00000318493,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Any cancer type,Responsive,MET,T1010I,c.3029C>T,chr7:g.116411990C>T,ENST00000318493,Crizotinib (ALK inhibitor)
Missense,Larotrectinib,Any cancer type,Resistant,NTRK1,G595R,c.1783G>A,chr1:g.156846342G>A,ENST00000524377,Larotrectinib (Topomyosine kinase inhibitor)
Missense,Entrectinib,Colorectal adenocarcinoma,Resistant,NTRK1,G595R,c.1783G>A,chr1:g.156846342G>A,ENST00000524377,"Pan-TK inhibitors (Entrectinib,etc)"
Missense,Entrectinib,Colorectal adenocarcinoma,Resistant,NTRK1,G667C,c.1999G>T,chr1:g.156849107G>T,ENST00000524377,"Pan-TK inhibitors (Entrectinib,etc)"
Missense,Larotrectinib,Any cancer type,Resistant,NTRK3,G623R,c.1867G>A,chr15:g.88476265C>T,ENST00000360948,Larotrectinib (Topomyosine kinase inhibitor)
Missense,Imatinib,Gastrointestinal stromal,Resistant,PDGFRA,D842V,c.2525A>T,chr4:g.55152093A>T,ENST00000257290,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Sunitinib,Gastrointestinal stromal,Resistant,PDGFRA,D842V,c.2525A>T,chr4:g.55152093A>T,ENST00000257290,Sunitinib (Pan-TK inhibitor)
Missense,Crenolanib,Gastrointestinal stromal,Responsive,PDGFRA,D842V,c.2525A>T,chr4:g.55152093A>T,ENST00000257290,Crenolanib (FLT3 inhibitor)
Missense,Dasatinib,Gastrointestinal stromal,Responsive,PDGFRA,D842V,c.2525A>T,chr4:g.55152093A>T,ENST00000257290,Dasatinib (BCR-ABL inhibitor 2nd gen)
Missense,Imatinib,Cutaneous melanoma,Responsive,PDGFRA,P577S,c.1729C>T,chr4:g.55141083C>T,ENST00000257290,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Cutaneous melanoma,Responsive,PDGFRA,R841K,c.2522G>A,chr4:g.55152090G>A,ENST00000257290,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Cutaneous melanoma,Responsive,PDGFRA,H845Y,c.2533C>T,chr4:g.55152101C>T,ENST00000257290,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Cutaneous melanoma,Responsive,PDGFRA,G853D,c.2558G>A,chr4:g.55152126G>A,ENST00000257290,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Imatinib,Hyper eosinophilic advanced snydrome,Resistant,PDGFRA,T674I,c.2021C>T,chr4:g.55144547C>T,ENST00000257290,Imatinib (BCR-ABL inhibitor 1st gen&KIT inhibitor)
Missense,Crenolanib,Cutaneous melanoma,Responsive,PDGFRA,V658A,c.1973T>C,chr4:g.55144144T>C,ENST00000257290,Crenolanib (FLT3 inhibitor)
Missense,Crenolanib,Cutaneous melanoma,Responsive,PDGFRA,P577S,c.1729C>T,chr4:g.55141083C>T,ENST00000257290,Crenolanib (FLT3 inhibitor)
Missense,Crenolanib,Cutaneous melanoma,Responsive,PDGFRA,R841K,c.2522G>A,chr4:g.55152090G>A,ENST00000257290,Crenolanib (FLT3 inhibitor)
Missense,Crenolanib,Cutaneous melanoma,Responsive,PDGFRA,H845Y,c.2533C>T,chr4:g.55152101C>T,ENST00000257290,Crenolanib (FLT3 inhibitor)
Missense,Crenolanib,Cutaneous melanoma,Responsive,PDGFRA,G853D,c.2558G>A,chr4:g.55152126G>A,ENST00000257290,Crenolanib (FLT3 inhibitor)
Missense,Ibrutinib,Chronic lymphocytic leukemia,Resistant,PLCG2,R665W,c.1993C>T,chr16:g.81946260C>T,ENST00000359376,Ibrutinib (BTK inhibitor)
Missense,Ibrutinib,Chronic lymphocytic leukemia,Resistant,PLCG2,L845F,c.2535A>T,chr16:g.81962183A>T,ENST00000359376,Ibrutinib (BTK inhibitor)
Missense,Cabozantinib,Thyroid,Responsive,RET,C634W,c.1902C>G,chr10:g.43609950C>G,ENST00000355710,Cabozantinib (Pan-kinase inhibitor)
Missense,Cabozantinib,Thyroid,Responsive,RET,M918T,c.2753T>C,chr10:g.43617416T>C,ENST00000355710,Cabozantinib (Pan-kinase inhibitor)
Missense,Sunitinib,Thyroid,Responsive,RET,C634W,c.1902C>G,chr10:g.43609950C>G,ENST00000355710,Sunitinib (Pan-TK inhibitor)
Missense,Sunitinib,Thyroid,Responsive,RET,M918T,c.2753T>C,chr10:g.43617416T>C,ENST00000355710,Sunitinib (Pan-TK inhibitor)
Missense,Ponatinib,Lung adenocarcinoma,Resistant,RET,I788N,c.2363T>A,chr10:g.43613899T>A,ENST00000355710,Ponatinib (BCR-ABL inhibitor 3rd gen&Pan-TK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ROS1,G2032R,c.6094G>A,chr6:g.117638347C>T,ENST00000368508,Crizotinib (ALK inhibitor)
Missense,Cabozantinib,Lung adenocarcinoma,Responsive,ROS1,G2032R,c.6094G>A,chr6:g.117638347C>T,ENST00000368508,Cabozantinib (Pan-kinase inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Resistant,ROS1,S1986Y,c.5957C>A,chr6:g.117639399G>T,ENST00000368508,Ceritinib (ALK inhibitor)
Missense,Ceritinib,Lung adenocarcinoma,Resistant,ROS1,S1986F,c.5957C>T,chr6:g.117639399G>A,ENST00000368508,Ceritinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ROS1,S1986Y,c.5957C>A,chr6:g.117639399G>T,ENST00000368508,Crizotinib (ALK inhibitor)
Missense,Crizotinib,Lung adenocarcinoma,Resistant,ROS1,S1986F,c.5957C>T,chr6:g.117639399G>A,ENST00000368508,Crizotinib (ALK inhibitor)
Missense,Lorlatinib,Lung adenocarcinoma,Responsive,ROS1,S1986Y,c.5957C>A,chr6:g.117639399G>T,ENST00000368508,Lorlatinib (ALK&ROS1 inhibitor)
Missense,Lorlatinib,Lung adenocarcinoma,Responsive,ROS1,S1986F,c.5957C>T,chr6:g.117639399G>A,ENST00000368508,Lorlatinib (ALK&ROS1 inhibitor)
Missense,Vismodegib,Medulloblastoma,Resistant,SMO,D473H,c.1417G>C,chr7:g.128849189G>C,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,D473H,c.1417G>C,chr7:g.128849189G>C,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,D473G,c.1418A>G,chr7:g.128849190A>G,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,W535L,c.1604G>T,chr7:g.128850341G>T,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,L412F,c.1234C>T,chr7:g.128846398C>T,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,W281C,c.843G>T,chr7:g.128845546G>T,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,Q477E,c.1429C>G,chr7:g.128849201C>G,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Basal cell carcinoma,Resistant,SMO,G497W,c.1489G>T,chr7:g.128850226G>T,ENST00000249373,Vismodegib (SHH inhibitor)
Missense,Vismodegib,Lung,Responsive,SMO,P641A,c.1921C>G,chr7:g.128851596C>G,ENST00000249373,Vismodegib (SHH inhibitor)
